Karl S Burgoyne, MD
Investigator, LA BioMed
Associate Professor of Psychiatry, David Geffen School of Medicine at UCLA
Training Director, General Psychiatry Program at Harbor-UCLA Medical Center
Contact
Antipsychiatrics & Antidepressants
Research Description
Dr. Burgoyne's primary clinical research focus involves second generation antipsychotics, many novel antidepressants, and some anxiolytics. Multicentered projects include CATIE and STAR-D. His more recent research efforts have focused on the prediction of antidepressant responses using quantitative EEG measurements.Education
- BS, University of Southern California
- MD, University of Southern California School of Medicine